Cargando…
Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19
Phosphatidylserine (PS) receptors are PS binding proteins that mediate uptake of apoptotic bodies. Many enveloped viruses utilize this PS/PS receptor mechanism to adhere to and internalize into the endosomal compartment of cells and this is termed apoptotic mimicry. For viruses that have a mechanism...
Autores principales: | Bohan, Dana, Ert, Hanora Van, Ruggio, Natalie, Rogers, Kai J., Badreddine, Mohammad, Aguilar Briseño, José A., Rojas Chavez, Roberth Anthony, Gao, Boning, Stokowy, Tomasz, Christakou, Eleni, Micklem, David, Gausdal, Gro, Haim, Hillel, Minna, John, Lorens, James B., Maury, Wendy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219095/ https://www.ncbi.nlm.nih.gov/pubmed/34159331 http://dx.doi.org/10.1101/2021.06.15.448419 |
Ejemplares similares
-
Phosphatidylserine receptors enhance SARS-CoV-2 infection
por: Bohan, Dana, et al.
Publicado: (2021) -
Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein
por: Van Ert, Hanora A., et al.
Publicado: (2022) -
AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction
por: Landolt, Lea, et al.
Publicado: (2019) -
Axl‐inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model
por: Hoel, August, et al.
Publicado: (2021) -
AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells
por: Lotsberg, Maria L., et al.
Publicado: (2020)